Growth Metrics

Coherus Oncology (CHRS) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to $49.5 million.

  • Coherus Oncology's Goodwill & Intangibles fell 889.11% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.5 million, marking a year-over-year decrease of 889.11%. This contributed to the annual value of $53.6 million for FY2024, which is 2515.17% down from last year.
  • Latest data reveals that Coherus Oncology reported Goodwill & Intangibles of $49.5 million as of Q3 2025, which was down 889.11% from $52.3 million recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Goodwill & Intangibles ranged from a high of $71.7 million in Q4 2023 and a low of $3.6 million during Q1 2021
  • Moreover, its 5-year median value for Goodwill & Intangibles was $6.0 million (2022), whereas its average is $28.3 million.
  • In the last 5 years, Coherus Oncology's Goodwill & Intangibles soared by 110844.71% in 2023 and then plummeted by 2515.17% in 2024.
  • Coherus Oncology's Goodwill & Intangibles (Quarter) stood at $3.6 million in 2021, then skyrocketed by 66.46% to $5.9 million in 2022, then soared by 1108.45% to $71.7 million in 2023, then dropped by 25.15% to $53.6 million in 2024, then decreased by 7.76% to $49.5 million in 2025.
  • Its Goodwill & Intangibles stands at $49.5 million for Q3 2025, versus $52.3 million for Q2 2025 and $53.0 million for Q1 2025.